BECK MACK & OLIVER LLC - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 41 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BECK MACK & OLIVER LLC ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$116,550
-32.7%
30,0000.0%0.00%
-40.0%
Q2 2023$173,100
-11.2%
30,0000.0%0.01%
-16.7%
Q1 2023$195,000
+18.2%
30,000
-50.0%
0.01%
+200.0%
Q4 2022$165,000
+87.5%
60,000
+100.0%
0.00%
-33.3%
Q3 2022$88,000
+51.7%
30,0000.0%0.00%
+50.0%
Q2 2022$58,000
-28.4%
30,000
+200.0%
0.00%0.0%
Q1 2022$81,000
-12.0%
10,0000.0%0.00%0.0%
Q4 2021$92,000
-26.4%
10,0000.0%0.00%
-33.3%
Q3 2021$125,000
+10.6%
10,0000.0%0.00%0.0%
Q2 2021$113,000
-25.7%
10,0000.0%0.00%
-40.0%
Q1 2021$152,000
+32.2%
10,0000.0%0.01%
+25.0%
Q4 2020$115,000
+49.4%
10,0000.0%0.00%
+33.3%
Q3 2020$77,000
-30.0%
10,0000.0%0.00%
-25.0%
Q2 2020$110,000
+0.9%
10,0000.0%0.00%
-20.0%
Q1 2020$109,000
-31.4%
10,0000.0%0.01%0.0%
Q4 2019$159,000
+7.4%
10,0000.0%0.01%0.0%
Q3 2019$148,000
+27.6%
10,0000.0%0.01%
+25.0%
Q2 2019$116,000
+7.4%
10,0000.0%0.00%0.0%
Q1 2019$108,000
+31.7%
10,0000.0%0.00%
+33.3%
Q4 2018$82,00010,0000.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Altium Capital Management LP 256,244$3,203,0000.84%
Perceptive Advisors 3,610,412$45,130,0000.66%
Orbimed Advisors 1,479,733$18,497,0000.20%
Fosun International Ltd 282,408$3,530,0000.18%
KORNITZER CAPITAL MANAGEMENT INC /KS 728,236$9,103,0000.14%
SteelPeak Wealth, LLC 133,161$1,665,0000.11%
HighVista Strategies LLC 10,944$137,0000.09%
Capital Investment Advisory Services, LLC 15,125$189,0000.02%
MML INVESTORS SERVICES, LLC 44,875$561,0000.00%
BECK MACK & OLIVER LLC 10,000$125,0000.00%
View complete list of VERRICA PHARMACEUTICALS INC shareholders